Alvotech (ALVO) vs Celldex Therapeutics, Inc. (CLDX)

A side-by-side comparison of Alvotech and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALVO vs CLDX

growth of $100 · dividends reinvested · last 4y
ALVO -45.4% (-14.0%/yr)CLDX +59.0% (+12.3%/yr)CLDX compounded faster over this window
50100150200250Start $1002023202420252026$55$159
ALVO CLDX

ALVO vs CLDX: by the numbers

  • •CLDX is the larger company ($2.17B vs $2.07B market cap).
  • •Both run net losses; ALVO's is the smaller (-36.51% vs -268385.71% net margin).
  • •ALVO grew revenue faster over the past five years (69.03% vs -58.05% CAGR).

Metrics side by side

Valuation

MetricALVOCLDX
P/S ratio4.2019361.50
P/B ratioN/A3.03
EV / EBITDA41.84N/A

Profitability

MetricALVOCLDX
Gross margin60.45%100.00%
Operating margin9.62%-19160.00%
Net margin-36.51%-268385.71%
ROEN/A-42.07%
ROIC3.61%-45.19%

Growth (annualized)

MetricALVOCLDX
Revenue CAGR (5Y)69.03%-58.05%
Total return CAGR (5Y)N/A-10.28%

Frequently asked

Which has grown faster, ALVO or CLDX?
Over the past five years, ALVO grew revenue faster — ALVO at a 69.03% CAGR versus CLDX at -58.05%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.